NSEAnalysts/Institutional Investor Meet/Con. Call Updates2d ago · 10 Nov 2026, 04:06 pm
Analysts/Institutional Investor Meet/Con. Call Updates
Global Health Limited · MEDANTA
✦ AI SummaryMgmt Change
Global Health Limited has informed the Exchange about a scheduled meeting with investors/analysts on November 16 and 17, 2026. The meeting will be held in person and will not involve the sharing of unpublished price-sensitive information.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Global Health Limited has informed the Exchange about Schedule of meet
Attachments (1)
📄pdf
Download →
MEDANTA21_10112026160319_GHLANALYSTSMEETNOVEMBER102026SIGNED.pdf
View document text
Date: November 10, 2026
Ref:- GHL/2026-27/EXCH/ 76
The General Manager The Manager
Dept. of Corporate Services Listing Department
BSE Limited, P J Towers, National Stock Exchange of India Limited
Dalal Street, Mumbai - 400 001 Exchange Plaza, C-1, Block G, Bandra Kurla
Complex, Bandra (E), Mumbai - 400 051
Scrip Code: 543654 Symbol: MEDANTA
Sub: Intimation for Schedule of Analyst/Institutional Investor Meeting.
Dear Sir(s),
Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015, we would like to inform you that the Company’s Management will meet
Investors/Analysts as per the below schedule:
Date of Meeting Name of Investor/Analyst Firm Type of Meeting Mode of Meeting
November 16, Fullerton Fund Management Co Ltd One to One In Person
2026
Eastspring Investments One to One In Person
Allianz Global Investors One to One In Person
North Rock Capital MGMT SG Pte One to One In Person
Nippon Capital One to One In Person
November 17, Aberdeen Investments One to One In Person
2026
Fidelity International Investment One to One In Person
Management
Nomura Asset Management One to One In Person
White Oak Capital One to One In Person
Please note that, no Unpublished Price Sensitive Information is proposed to be shared, thereat.
Note: Please note that the above meeting is subject to change in case of any unforeseen circumstances, on
the part of Analysts/Investors/Company.
Kindly take the above on record.
For Global Health Limited
Rahul Ranjan
Company Secretary & Compliance Officer
M. No. A17035
Regd. Office: E-18, Defence Colony, New Delhi 110024, Ph No.011- 44114411 www.medanta.org, info@medanta.org, CIN: L85110DL2004PLC128319